These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2643726)

  • 41. [Study of growth fraction on fine needle aspirated prostatic tissue smear using monoclonal antibody Ki-67].
    Sai S; Takashi M; Miyake K; Koshikawa T
    Hinyokika Kiyo; 1991 Aug; 37(8):881-6. PubMed ID: 1957731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining.
    Raymond WA; Leong AS; Bolt JW; Milios J; Jose JS
    J Pathol; 1988 Oct; 156(2):161-7. PubMed ID: 3058914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.
    White RA; Meistrich ML; Pollack A; Terry NH
    Cytometry; 2000 Sep; 41(1):1-8. PubMed ID: 10942890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell proliferation of human bladder tumors.
    Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
    J Urol; 1989 Oct; 142(4):1113-6. PubMed ID: 2795741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
    Currin SM; Lee SE; Walther PJ
    J Urol; 1988 Jul; 140(1):96-100. PubMed ID: 2837590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The proliferative activity of neurilemomas.
    Lee KS; Nagashima T; Cho KG; Mampalam TJ; Pitts LH; Hoshino T
    Surg Neurol; 1989 Dec; 32(6):427-33. PubMed ID: 2700052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.
    Veronese S; Gambacorta M; Falini B
    J Clin Pathol; 1989 Aug; 42(8):820-6. PubMed ID: 2475528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.
    Gallee MP; Visser-de Jong E; ten Kate FJ; Schroeder FH; Van der Kwast TH
    J Urol; 1989 Nov; 142(5):1342-6. PubMed ID: 2478729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The proliferative potential of human pituitary tumors in situ.
    Nagashima T; Murovic JA; Hoshino T; Wilson CB; DeArmond SJ
    J Neurosurg; 1986 Apr; 64(4):588-93. PubMed ID: 3950742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Astrocytic proliferation in the brain adjacent to infarcted lesion: immunohistochemical study of astroprotein (GFAP) and bromodeoxyuridine (BrdU)].
    Takemoto O; Yoshimine T; Hayakawa T; Fujita T; Nakajima S; Taneda M; Mogami H
    No To Shinkei; 1989 Apr; 41(4):361-5. PubMed ID: 2765300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
    Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
    Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies with anti-bromodeoxyuridine antibodies: II. Simultaneous immunocytochemical detection of antigen expression and DNA synthesis by in vivo labeling of mouse intestinal mucosa.
    Schutte B; Reynders MM; Bosman FT; Blijham GH
    J Histochem Cytochem; 1987 Mar; 35(3):371-4. PubMed ID: 3546484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Flow cytometric cell cycle analysis using a monoclonal antibody to bromodeoxyuridine on gastric cancers].
    Ohyama S; Yonemura Y; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1848-54. PubMed ID: 2608014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical demonstration with anti-bromodeoxyuridine monoclonal antibody in experimental meningeal carcinomatosis model.
    Huang TY; Hwang SL; Howng SL
    Kaohsiung J Med Sci; 1997 Mar; 13(3):136-40. PubMed ID: 9109299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.
    Danova M; Riccardi A; Brugnatelli S; Fiocca R; Girino M; Villani L; Giordano P; Dionigi P; Giordano M; Buttini R
    Histochem J; 1988 Mar; 20(3):125-30. PubMed ID: 2842278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo measurement of breast cancer growth rate.
    Goodson WH; Ljung BM; Waldman F; Mayall B; Chew K; Moore DH; Smith H; Goldman ES; Benz C
    Arch Surg; 1991 Oct; 126(10):1220-3; discussion 1223-4. PubMed ID: 1929822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
    Gunduz N
    Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunohistochemical study of S-phase cells in human gliomas].
    Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
    No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
    Raza A; Ucar K; Preisler HD
    Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.